John Trainer
Chief Operating Officer at IMMUNOCORE HOLDINGS PLC
Profile
John Trainer currently works at Corvidia Therapeutics, Inc., as Director, Fujifilm Kyowa Kirin Biologics Co., Ltd., as Director, Archigen Biotech Ltd., as Director, and Immunocore Holdings Plc, as Chief Operating Officer & Senior Vice President from 2023.
Mr. Trainer also formerly worked at NexImmune, Inc., as Chief Financial Officer from 2020 to 2023 and AstraZeneca, Inc., as Vice President & Head-Partnering & Strategy.
Mr. Trainer received his Masters Business Admin degree from Harvard Business School and undergraduate degree from Harvard College.
John Trainer active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Operating Officer | 01/10/2023 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Director/Board Member | - |
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Director/Board Member | - |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
 Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Director/Board Member | - |
Former positions of John Trainer
| Companies | Position | End |
|---|---|---|
| NEXIMMUNE, INC. | Director of Finance/CFO | 02/09/2023 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
Training of John Trainer
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private companies | 4 |
|---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. is a Japanese company that is not well described by the given metadata. The joint venture company is based in Tokyo, Japan. However, based on the company name, it is likely that they are involved in the biotechnology or pharmaceutical industry. The company was founded in 2012. The CEO is Yoshifumi Torii. | Health Technology |
Archigen Biotech Ltd.
Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Health Technology |
- Stock Market
- Insiders
- John Trainer
